Biohit Oyj B (BIOBV) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Biohit Oyj B (BIOBV) has a cash flow conversion efficiency ratio of 0.040x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (€600.00K ≈ $701.46K USD) by net assets (€14.90 Million ≈ $17.42 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See Biohit Oyj B balance sheet quality to measure how much of total assets are equity-financed.
Biohit Oyj B - Cash Flow Conversion Efficiency Trend (2000–2025)
This chart illustrates how Biohit Oyj B's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check BIOBV cash to earnings ratio to evaluate the quality of earnings relative to operating cash generation.
Biohit Oyj B Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Biohit Oyj B ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Batavia Prosperindo Finance
JK:BPFI
|
-0.123x |
|
Sunny Elec
KO:004770
|
0.021x |
|
Acanthe Développement
PA:ACAN
|
-0.049x |
|
Tinka Resources Limited
V:TK
|
-0.006x |
|
Manomay Tex India Limited
NSE:MANOMAY
|
-0.109x |
|
Eastern Star Real Estate Public Company Limited
BK:ESTAR
|
-0.003x |
|
Yotta Acquisition Corporation Common Stock
NASDAQ:YOTA
|
-0.116x |
|
Beshom Holdings Bhd
KLSE:7668
|
0.033x |
Annual Cash Flow Conversion Efficiency for Biohit Oyj B (2000–2025)
The table below shows the annual cash flow conversion efficiency of Biohit Oyj B from 2000 to 2025. For the full company profile with market capitalisation and key ratios, see BIOBV company net worth.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | €14.90 Million ≈ $17.42 Million |
€-700.00K ≈ $-818.37K |
-0.047x | -197.81% |
| 2024-12-31 | €12.20 Million ≈ $14.26 Million |
€586.00K ≈ $685.10K |
0.048x | -49.81% |
| 2023-12-31 | €9.43 Million ≈ $11.02 Million |
€902.00K ≈ $1.05 Million |
0.096x | -61.38% |
| 2022-12-31 | €7.46 Million ≈ $8.72 Million |
€1.85 Million ≈ $2.16 Million |
0.248x | +507.40% |
| 2021-12-31 | €7.30 Million ≈ $8.53 Million |
€-444.00K ≈ $-519.08K |
-0.061x | -2017.33% |
| 2020-12-31 | €8.70 Million ≈ $10.17 Million |
€-25.00K ≈ $-29.23K |
-0.003x | -150.46% |
| 2019-12-31 | €14.58 Million ≈ $17.05 Million |
€83.00K ≈ $97.04K |
0.006x | +197.28% |
| 2018-12-31 | €15.89 Million ≈ $18.58 Million |
€-93.00K ≈ $-108.73K |
-0.006x | +89.30% |
| 2017-12-31 | €17.24 Million ≈ $20.16 Million |
€-943.00K ≈ $-1.10 Million |
-0.055x | +76.07% |
| 2016-12-31 | €10.75 Million ≈ $12.57 Million |
€-2.46 Million ≈ $-2.87 Million |
-0.229x | +25.12% |
| 2015-12-31 | €10.31 Million ≈ $12.05 Million |
€-3.15 Million ≈ $-3.68 Million |
-0.305x | -12.65% |
| 2014-12-31 | €12.68 Million ≈ $14.82 Million |
€-3.44 Million ≈ $-4.02 Million |
-0.271x | -36.91% |
| 2013-12-31 | €22.45 Million ≈ $26.25 Million |
€-4.44 Million ≈ $-5.19 Million |
-0.198x | +20.99% |
| 2012-12-31 | €35.49 Million ≈ $41.49 Million |
€-8.89 Million ≈ $-10.39 Million |
-0.250x | -367.03% |
| 2011-12-31 | €52.85 Million ≈ $61.78 Million |
€4.96 Million ≈ $5.80 Million |
0.094x | -37.80% |
| 2010-12-31 | €13.00 Million ≈ $15.20 Million |
€1.96 Million ≈ $2.29 Million |
0.151x | -31.23% |
| 2009-12-31 | €12.75 Million ≈ $14.90 Million |
€2.80 Million ≈ $3.27 Million |
0.219x | +130.61% |
| 2008-12-31 | €12.49 Million ≈ $14.60 Million |
€1.19 Million ≈ $1.39 Million |
0.095x | +8.29% |
| 2007-12-31 | €11.84 Million ≈ $13.84 Million |
€1.04 Million ≈ $1.22 Million |
0.088x | +1078.15% |
| 2006-12-31 | €13.41 Million ≈ $15.68 Million |
€100.00K ≈ $116.91K |
0.007x | -82.44% |
| 2005-12-31 | €14.25 Million ≈ $16.66 Million |
€605.00K ≈ $707.31K |
0.042x | -73.18% |
| 2004-12-31 | €14.14 Million ≈ $16.53 Million |
€2.24 Million ≈ $2.62 Million |
0.158x | +158.63% |
| 2003-12-31 | €14.10 Million ≈ $16.49 Million |
€863.00K ≈ $1.01 Million |
0.061x | -46.71% |
| 2001-12-31 | €16.33 Million ≈ $19.10 Million |
€1.88 Million ≈ $2.19 Million |
0.115x | +110.71% |
| 2000-12-31 | €98.02 Million ≈ $114.60 Million |
€5.34 Million ≈ $6.25 Million |
0.055x | -- |
About Biohit Oyj B
Biohit Oyj, a biotechnology company, manufactures and sells bind acetaldehyde, diagnostic products, and systems for diagnostic analysis for the use of research institutions, healthcare, and industry worldwide. The company's diagnostic tests product includes the GastroPanel Unified test panel for stomach health check; GastroPanel Four-in-One stomach test; GastroSoft software application to assist … Read more